Jennifer J. Schlezinger, PhD

Associate Professor, Environmental Health
Jennifer Schlezinger
(617) 358-1708jschlezi@bu.edu
Housman (R Bldg) – R-4
View full profile at BUMC

Biography

Dr. Schlezinger received her B.S. from Boston College in 1992 and her Ph.D. from the Massachusetts Institute of Technology and Woods Hole Oceanographic Institution Joint Program in Biological Oceanography in 1998. Dr. Schlezinger is an active member of the Society of Toxicology. Her PhD research involved the study of the molecular mechanisms of PCB toxicity in a marine fish model. Coming to Boston University School of Public Health as a post-doctoral researcher in 1998, she worked closely with Dr. David Sherr on investigating the immuntoxicity of polycyclic aromatic hydrocarbons. Now, the overarching goal of her laboratory’s research is to determine how exposure to environmental toxicants impair bone and adipose homeostasis, which lays the foundation for osteoporosis and metabolic disease. Dr. Schlezinger's lab investigates nuclear receptor activation (e.g. PPARg, RXRs, LXRs) in bone forming cells and the physiological impact of environmental chemical-driven changes in the activities of these receptors. they also investigate the hypothesis that environmental obesogen-driven changes in the balance of adipocyte and osteoblast differentiation from multipotent mesenchymal stromal cells underlies susceptibility to loss of bone. Adipocyte differentiation in bone marrow is a feature of aging and a significant contributor to osteoporosis. The lab has expanded its focus to include examining the role of environmental toxicants in development of metabolic disease. They are testing the novel hypothesis that environmental ligands selectively activate PPARg’s activities, contributing to the development of pathological adipose tissue and metabolic dyshomeostasis. This work has been built upon their identification of a novel environmental PPARg ligand, triphenyl phosphate, which is a component of the obesity-inducing flame retardant mixture Firemaster 550. The newest aspect of Dr. Schlezinger's research is an investigation of the impact of early life exposure on life-long metabolic and bone health.

Other Positions

  • Graduate Faculty (Primary Mentor of Grad Students), Boston University School of Medicine, Graduate Medical Sciences

Education

  • Massachusetts Institute of Technology, PhD
  • Boston College, BS

Classes Taught

  • SPHEH705
  • SPHEH961

Publications

  • Published on 7/19/2018

    Kim S, Li A, Monti S, Schlezinger JJ. Tributyltin induces a transcriptional response without a brite adipocyte signature in adipocyte models. Arch Toxicol. 2018 Sep; 92(9):2859-2874. PMID: 30027469.

    Read at: PubMed
  • Published on 5/7/2018

    Narasimhan S, Stanford Zulick E, Novikov O, Parks AJ, Schlezinger JJ, Wang Z, Laroche F, Feng H, Mulas F, Monti S, Sherr DH. Towards Resolving the Pro- and Anti-Tumor Effects of the Aryl Hydrocarbon Receptor. Int J Mol Sci. 2018 May 07; 19(5). PMID: 29735912.

    Read at: PubMed
  • Published on 3/25/2018

    Watt J, Baker AH, Meeks B, Pajevic PD, Morgan EF, Gerstenfeld LC, Schlezinger JJ. Tributyltin induces distinct effects on cortical and trabecular bone in female C57Bl/6J mice. J Cell Physiol. 2018 Sep; 233(9):7007-7021. PMID: 29380368.

    Read at: PubMed
  • Published on 7/1/2017

    Baker AH, Wu TH, Bolt AM, Gerstenfeld LC, Mann KK, Schlezinger JJ. From the Cover: Tributyltin Alters the Bone Marrow Microenvironment and Suppresses B Cell Development. Toxicol Sci. 2017 Jul 01; 158(1):63-75. PMID: 28398592.

    Read at: PubMed
  • Published on 2/8/2017

    Kassotis CD, Masse L, Kim S, Schlezinger JJ, Webster TF, Stapleton HM. Characterization of Adipogenic Chemicals in Three Different Cell Culture Systems: Implications for Reproducibility Based on Cell Source and Handling. Sci Rep. 2017 02 08; 7:42104. PMID: 28176856.

    Read at: PubMed
  • Published on 6/2/2016

    Watt J, Webster TF, Schlezinger JJ. Generalized Concentration Addition Modeling Predicts Mixture Effects of Environmental PPAR? Agonists. Toxicol Sci. 2016 Sep; 153(1):18-27. PMID: 27255385.

    Read at: PubMed
  • Published on 3/15/2016

    Auerbach S, Filer D, Reif D, Walker V, Holloway AC, Schlezinger J, Srinivasan S, Svoboda D, Judson R, Bucher JR, Thayer KA. Prioritizing Environmental Chemicals for Obesity and Diabetes Outcomes Research: A Screening Approach Using ToxCast™ High-Throughput Data. Environ Health Perspect. 2016 Aug; 124(8):1141-54. PMID: 26978842.

    Read at: PubMed
  • Published on 2/9/2016

    Bolt AM, Grant MP, Wu TH, Flores Molina M, Plourde D, Kelly AD, Negro Silva LF, Lemaire M, Schlezinger JJ, Mwale F, Mann KK. Tungsten Promotes Sex-Specific Adipogenesis in the Bone by Altering Differentiation of Bone Marrow-Resident Mesenchymal Stromal Cells. Toxicol Sci. 2016 Apr; 150(2):333-46. PMID: 26865663.

    Read at: PubMed
  • Published on 5/13/2015

    Baker AH, Watt J, Huang CK, Gerstenfeld LC, Schlezinger JJ. Tributyltin engages multiple nuclear receptor pathways and suppresses osteogenesis in bone marrow multipotent stromal cells. Chem Res Toxicol. 2015 Jun 15; 28(6):1156-66. PMID: 25932594.

    Read at: PubMed
  • Published on 3/14/2015

    Watt J, Schlezinger JJ. Structurally-diverse, PPAR?-activating environmental toxicants induce adipogenesis and suppress osteogenesis in bone marrow mesenchymal stromal cells. Toxicology. 2015 May 4; 331:66-77. PMID: 25777084.

    Read at: PubMed

View 40 more publications:View full profile at BUMC

News & In the Media